CD147-shRNA对肝癌细胞CD147表达的抑制作用
作者:
通讯作者:
作者单位:

作者简介:

房学东E-mail:lukepie@sina.com

基金项目:


The inhibitory effect of CD147-shRNA on expression of CD147 of hepatoma cell line SMMC-7721 and HepG2
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    目的:构建CD147-shRNA重组质粒并检测其对肝癌细胞SMMC-7721和HepG2内源性CD147表达的抑制作用。
    方法:根据Genebank中CD147序列设计3条特征性靶序列,合成的核苷酸序列连接到线性化pBS/U6载体,采用酶切法及测序鉴定重组质粒的正确性;将重组质粒转染至人肝癌细胞SMMC-7721和HepG2中,采用Western blot法和免疫荧光法观察该重组质粒对CD147内源性表达的抑制作用。
    结果:酶切鉴定和测序证实成功构建pBS/U6/CD147-shRNA,且对人肝癌细胞SMMC-7721和HepG2 CD147表达有抑制作用,而以pBS/U6/CD147-shRNA3抑制作用最为显著。
    结论:构建pBS/U6/CD147-shRNA成功,并筛选出基因抑制效果最佳的pBS/U6/CD147-shRNA3,为进一步实验打下了基础。

    Abstract:

    Objective: To construct recombinant plasmid CD147-shRNA and detect its inhibitory effect on CD147 expression of hepatoma cell line SMMC- 7721 and HepG2.
    Methods: Three characteristic target sequences were designed according to the sequence of CD147 in Genebank,and the synthesized polynucleotide was connected to pBS/U6.The recombinant plasmid was identified by restriction enzyme digestion and sequencing and transfected into hepatoma cells SMMC-7721 and HepG2. The expression of CD147 was detected by Western blot and immunofluorescence.
    Results: CD147-shRNAs recombinant plasmid was completely and correctly constructed comfirmed by restriction enzyme digestion and sequencing. All the plasmids had gene silencing effect on CD147 expression of HepG2, but the inhibit effect of pBS/U6/CD147- shRNA3 was most significant.
    Conclusions: We succesfully constructed pBS/U6/CD147-shRNA and screened out pBS/U6/CD147-shRNA3 which has the best gene silence effect.

    参考文献
    相似文献
    引证文献
引用本文

宫路路|林瑞新|李晓萌|张爱丽|文海荣|房学东. CD147-shRNA对肝癌细胞CD147表达的抑制作用[J].中国普通外科杂志,2010,19(1):41-47.
DOI:10.7659/j. issn.1005-6947.2010.01.010

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2009-10-06
  • 最后修改日期:2009-12-28
  • 录用日期:
  • 在线发布日期: 2010-01-15